Name: UMIN ID:
Unique ID issued by UMIN | UMIN000000931 |
---|---|
Receipt number | R000001115 |
Scientific Title | Clinical study to investigate safety and efficacy on combination of gemcitabine and autologous gamma/delta T cell transfer therapy after resection of pancreatic cancer |
Date of disclosure of the study information | 2007/12/05 |
Last modified on | 2015/06/05 10:14:53 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2007/12/05 12:47:40 | ||
2 | Update | 2007/12/25 16:11:09 | Name of person sending information Name of person sending information |
|
3 | Update | 2008/07/17 09:44:07 | UMIN ID1 |
|
4 | Update | 2008/07/17 22:26:58 | Condition Condition |
|
5 | Update | 2008/07/17 22:27:49 | Key inclusion criteria Key inclusion criteria |
|
6 | Update | 2009/03/03 10:21:58 | Email |
|
7 | Update | 2009/11/18 18:42:58 | Division name Division name Address Address TEL |
|
8 | Update | 2009/11/18 18:43:29 | Recruitment status |
|
9 | Update | 2009/12/22 14:26:43 | Recruitment status |
|
10 | Update | 2010/12/08 15:50:16 | Interventions/Control_1 Interventions/Control_1 |
|
11 | Update | 2011/01/13 16:47:55 | Key inclusion criteria |
|
12 | Update | 2011/01/13 16:48:48 | Last follow-up date |
|
13 | Update | 2014/01/08 11:39:02 | Recruitment status |
|
14 | Update | 2014/06/06 09:24:47 | Last follow-up date |
|
15 | Update | 2014/12/10 11:39:56 | Email Division name Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
16 | Update | 2015/06/05 10:14:53 | Recruitment status |